REVB Q1 2026 Earnings Significant EPS Miss as PreRevenue Biotech Reports Operating Loss RBLX Q1 2026 Earnings EPS Beats Estimates Significantly Stock Rises on Narrower Loss PHIO Q1 2026 Earnings EPS Misses Estimates Amid Continued Clinical Trials Focus CSL Q1 2026 Earnings Strong EPS Beat Highlights Operational Efficiency MED Q1 2026 Earnings EPS Surprises with Smaller Loss Than Expected CPSH Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds